ThermoFisher expects revenue growth in the 3–6% range for 2026 and 2027, and a growth rate of 7% or more in 2028 and beyond.
Konstantinopoulos, M.D., Ph.D., Dana-Farber Cancer Institute, will highlight company’s recent interim clinical data from the ongoing, registrational-intent Phase 2b study of ACR-368 in subjects with ...
HIGHLANDS RANCH, CO - January 20, 2026 - PRESSADVANTAGE - Mid Solid Press & Pour has announced modifications to its ...
Modern Engineering Marvels on MSNOpinion
The Navy’s F/A-XX delay is turning engineers into wasted capability
A sixth-generation carrier fighter stuck on the PowerPoint presentation becomes a problem of the industrial base as much as ...
Detailed price information for Tivic Health Systems Inc (TIVC-Q) from The Globe and Mail including charting and trades.
Ethereum commits $2M to quantum defense team as blockchain faces accelerating quantum computing threats within years, not ...
SHENZHEN, GUANGDONG PROVINCE, CHINA, January 21, 2026 /EINPresswire.com/ -- In today’s rapidly evolving industrial and ...
January 08, 2026 - PRESSADVANTAGE - Silverback Webinar has announced continued development and refinement of its ...
KRAFTON held KRAFTON LIVE TALK (KLT) on the 15th—an internal communications program—to unveil its 2026 management strategy ...
Regeneron's strategy focuses on a broad pipeline across six therapeutic areas, with significant near-term data readouts ...
Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results